Visen Medical, Inc.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
11
Ending by 2030
Feb 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 12, 2027The maintenance fee for 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof (US 10,473,658) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Aug 20, 2027The maintenance fee for Systems, Methods, and Apparatus for Imaging of Diffuse Media Featuring Cross-Modality Weighting of Fluorescent and Bioluminescent Sources (US 11,903,675) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
- 1 fee due Oct 12, 2027The maintenance fee for Imaging Systems Featuring Waveguiding Compensation (US 9,311,722) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 23, 2026
- Sep 1 US 8,455,651 Nicotinic Acid and Picolinic Acid Derived Near-Infrared Fluorophores · term ended
- Sep 1 US 10,442,930 Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,365,721 | Polycyclo dyes and use thereof In force · USPTO record | In force | USPTO record | |
| US 9,574,085 | Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels In force · USPTO record | In force | USPTO record | |
| US 8,653,480 | Imaging Systems Featuring Waveguiding Compensation In force · High confidence | In force | High confidence | |
| US 9,311,722 | Imaging Systems Featuring Waveguiding Compensation In force · High confidence | In force | High confidence | |
| US 8,173,819 | Nicotinic and Picolinic Acid Derived Near-Infrared Fluorophores In force · High confidence | In force | High confidence | |
| US 9,427,481 | Fluorescent imaging agents In force · USPTO record | In force | USPTO record | |
| US 9,999,687 | Fluorescent imaging agents In force · USPTO record | In force | USPTO record | |
| US 8,918,163 | Animal Holder for in Vivo Tomographic Imaging with Multiple Modalities In force · High confidence | In force | High confidence | |
| US 10,064,584 | Combined x-ray and optical tomographic imaging system In force · High confidence | In force | High confidence | |
| US 10,092,188 | Methods and compositions for identifying subjects at risk of developing stent thrombosis In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 26: 4 patents in force now held by others · 4 lapsed for an unpaid fee · 17 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 4 no status recorded